SPRY UPCOMING DEADLINE: SueWallSt Alerts ARS Pharmaceuticals Inc. Stockholders of Securities Class Action - Contact the Firm
SueWallSt, powered by plaintiff firm Levi & Korsinsky, is alerting ARS Pharmaceuticals (NASDAQ: SPRY) stockholders of a pending securities class action on behalf of purchasers between March 9, 2026 and June 24, 2026, with October 5, 2026 set as the lead-plaintiff application deadline. The suit alleges ARS failed to disclose the risk that CVS Caremark's rigid formulary cycle could push a neffy coverage decision to January 2027; SPRY fell 23.9%, or $2.52 per share, in a single session after the June 24, 2026 update revealed no decision in the July 1 cycle.
Key figures
- Class period
- March 9, 2026 to June 24, 2026
- Stock drop pct
- 23.9%
- Cash pay program price
- $199
- Lead plaintiff deadline
- October 5, 2026
- Prior auth approval rate
- 55%
- Stock drop usd per share
- 2.52
- Commercial coverage end 2025
- 93%
- Caremark decision reserved until
- January 2027
- Covered lives without prior auth
- 57%
AI analysis
Red flags3 · Pro
The rest of the AI analysis, red flags and sentiment are part of Signal8 Pro.
AI-generated analysis of a public disclosure. Not investment advice; verify against the original document.